Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

May 31, 2011

Conditions
Biliary Tract Surgical ProceduresPancreaticoduodenectomyEsophagectomyColectomyGastrectomy
Interventions
DRUG

Tranexamic acid + Standard of Care

Tranexamic acid given slowly intravenously (15 mg/kg body weight) 15 minutes before surgery followed by a second dose at three hour interval from first dose and third dose at three hour interval from the second + standard of care (Standard of care includes the routine surgical and anesthetic techniques being utilized to control blood loss)

PROCEDURE

Standard of Care

Standard of care includes the routine surgical and anesthetic techniques being utilized to control blood loss

Trial Locations (2)

395 001

Pfizer Investigational Site, Surat

390 001

Pfizer Investigational Site, Vadodara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY